Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Shinyu Izumi and Masashi Mizokami.
Shinyu Izumi
Connection Strength
0.398
Masashi Mizokami
  1. Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. Gene. 2021 Jan 15; 766:145145.
    View in: PubMed
    Score: 0.226
  2. HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure. Front Immunol. 2021; 12:658570.
    View in: PubMed
    Score: 0.059
  3. Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19. J Clin Apher. 2021 Jun; 36(3):313-321.
    View in: PubMed
    Score: 0.057
  4. Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers. Crit Care Explor. 2020 Aug; 2(8):e0170.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.